VERA

VERA THERAPEUTICS INC

VERA·92337R101·US·Common Stock·Healthcare - Biotechnology-Activist

VERA (VERA THERAPEUTICS INC) is held by 125 institutional investors as of Q1 2026. Largest holders: Avoro Capital Advisors LLC ($236.9M), BlackRock, Inc. ($204.7M), PRICE T ROWE ASSOCIATES INC /MD/ ($184M). Net institutional sentiment: Bullish.

125
Holders
Avg rating(23 Elite)
$1.8B
Total Value
67% (132)
Fund Consensus
83 buying - 41 selling
VERASmart Money Verdict
View all
Held by 125 funds
23 elite
Who's Trading
InsiderFMFordyce MarshallSell $41KJul 7, 2026
InsiderFMFordyce MarshallSell $1.4MJul 7, 2026
InsiderFMFordyce MarshallSell $450KJul 7, 2026
InsiderFMFordyce MarshallSell $96KJul 7, 2026
InsiderFMFordyce MarshallSell $698KJun 23, 2026
InsiderFMFordyce MarshallSell $3KJun 23, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.6.4%May 15, 2026
InsiderFMFordyce MarshallSell $617KApr 14, 2026
InsiderFMFordyce MarshallSell $353KApr 14, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.1.7%Apr 1, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.9M$236.9M2.3%+3.15%
0
Increased
5.1M(+5.4%)$204.7M0.0%+0.17%
32
Decreased
4.6M(-16.3%)$184M0.0%-3.74%
0
Increased
3.4M(+25.7%)$135.3M0.0%+50.12%
37
New
2.7M$108M0.0%+6.87%
42
Decreased
2.7M(-7.3%)$107.7M0.0%+1.57%
0
Increased
1.3M(+7.8%)$66.6M0.0%-14.54%
32
Increased
1.6M(+8.7%)$63.2M0.0%+53.93%
32
Decreased
1.2M(-30.4%)$48.7M0.1%+20.43%
0
Increased
1.1M(+1.2%)$45.6M0.0%+0.02%
29
Decreased
1.1M(-24.5%)$42.3M0.0%+63.66%
0
Increased
1M(+0.1%)$40.3M0.2%+47.08%
35
Decreased
728,330(-0.6%)$29.3M0.0%+36.35%
0
Decreased
589,684(-15.1%)$23.7M0.0%+24.03%
0
New
552,971$22.2M0.0%+6.87%
39
Increased
551,493(+48.6%)$22.2M0.2%-11.18%
47
Increased
541,799(+43.3%)$21.8M0.0%+21.39%
38
Increased
532,466(+53.3%)$21.4M0.0%+49.13%
40
Increased
524,562(+1.1%)$21.1M0.0%+53.86%
29
Increased
519,445(+9.8%)$20.9M0.0%+62.97%
31

Showing 1-20 of 132

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used